4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow opicapone: new trials by email Literature Review of opicapone trials Research Report on opicapone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study) Opicapone 50 mg, Placebo - Parkinson | Phase 3 | Completed | Bial - Portela C S.A. | 410 | 2021-05-31 | 2025-03-12 |
| Continuation Treatment Protocol for Patient Who Participated in the BIA 9-1067-302 Clinical Trial Opicapone - Parkinson Disease | Phase 3 | Completed | Rabin Medical Center | 1 | 2013-05-01 | 2020-03-16 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon BIA 9-1067, Entacapone, Placebo - Parkinson's Disease | Phase 3 | Completed | Bial - Portela C S.A. | 600 | 2011-03-01 | 2015-09-18 |
| Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients. BIA 9-1067, Placebo, Levodopa - Parkinson's Disease | Phase 3 | Completed | Bial - Portela C S.A. | 427 | 2011-03-01 | 2015-10-19 |
Parkinson Disease (3) · Dyskinesias (1)
Bial - Portela C S.A. (3) · Rabin Medical Center (1)
Portugal (2) · Bulgaria (1) · Israel (1)